MARGARET KENT: Open Payments
NPI 1801888573 · ELLICOTTVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 67 payments from 9 companies in 2025. Trend: 2023 $626 · 2024 $853 · 2025 $1,336
Food & beverage: $1,226Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $416 |
| Alkermes, Inc. | 14 | $256 |
| Otsuka America Pharmaceutical, Inc. | 6 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $176 |
| ABBVIE INC. | 10 | $135 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Lundbeck LLC | 1 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: UZEDY, ARISTADA, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, COBENFY, AUSTEDO XR, REXULTI.
Industry payments across NY — which companies pay providers there.
